Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
03-06 November, 2024
2024 ACI Convention2024 ACI Convention
Not Confirmed
Not Confirmed
03-07 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
03-06 November, 2024
2024 ACI Convention2024 ACI Convention
Industry Trade Show
Not Confirmed
03-07 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
07 Nov 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/amytrx-therapeutics-welcomes-two-renowned-scientists-to-its-board-of-directors-301978879.html
25 Jul 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/amytrx-therapeutics-amtx-100-phase-1-clinical-trial-data-presented-at-revolutionizing-atopic-dermatitis-conference-301885634.html
28 Jun 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/amytrx-therapeutics-announces-open-enrollment-for-phase-2b-clinical-trial-of-amtx-100-cf3-a-promising-anti-inflammatory-peptide-therapeutic-for-atopic-dermatitis-301866172.html
27 Jul 2022
// BUSINESSWIRE
09 Jun 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/amytrx-therapeutics-amtx-100-cf3-moves-to-phase-ii-clinical-trial-for-atopic-dermatitis-301565077.html
26 May 2022
// Paul Schloesser ENDPTS
https://endpts.com/two-years-post-stealth-exit-highly-secretive-inflammation-biotech-secures-final-tranche-of-series-a-round/
ABOUT THIS PAGE
Amytrx Therapeutics is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of AMTX-100 CF3 CMC bulk with DMF offered by Amytrx Therapeutics
LOOKING FOR A SUPPLIER?